Tryptanthrin是一种天然的生物碱化合物,具有基础的吲哚喹啉唑骨架。它具有广谱的生物活性,包括抗癌、抗炎、抗原虫、抗过敏、抗氧化和抗微生物等作用。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| Concentration | Treated Time | Description | References | |
| Acinetobacter baumannii ATCC 17978 | 20 mg/mL | 24 h | Inhibited biofilm formation, inhibition rate 59% | iScience. 2024 May 8;27(6):109942. |
| Acinetobacter baumannii AB102 | 20 mg/mL | 24 h | Inhibited biofilm formation, inhibition rate 85% | iScience. 2024 May 8;27(6):109942. |
| Acinetobacter baumannii AB108 | 20 mg/mL | 24 h | Inhibited biofilm formation, inhibition rate 63% | iScience. 2024 May 8;27(6):109942. |
| normal murine peritoneal macrophages | ≤7.5 μM | Tryptanthrin showed no significant cytotoxicity on normal murine peritoneal macrophages at concentrations inhibitory to leukemia cells. | Cell Mol Immunol. 2009 Oct;6(5):335-42. | |
| murine myelomonocytic leukemia WEHI-3B JCS cells | 1-5 μM | 48-72 h | Tryptanthrin suppressed the proliferation of WEHI-3B JCS cells in a dose- and time-dependent manner, with an IC50 of 1.5 μM. | Cell Mol Immunol. 2009 Oct;6(5):335-42. |
| HepG2 | 1.25, 2.5, 5, 10 μM | 72 h | Induces cellular senescence and inhibits proliferation of liver cancer cells | Redox Biol. 2024 Oct;76:103323. |
| Huh7 | 1.25, 2.5, 5, 10 μM | 72 h | Induces cellular senescence and inhibits proliferation of liver cancer cells | Redox Biol. 2024 Oct;76:103323. |
| B16F10 | 11 µM | 72 h | Evaluate the cytotoxicity of Tpn on B16F10 cells, results showed IC50 was 11 µM | Cell Mol Life Sci. 2022 Aug 10;79(9):478. |
| SK-MEL-2 | 15 µM | 72 h | Evaluate the cytotoxicity of Tpn on SK-MEL-2 cells, results showed IC50 was 15 µM | Cell Mol Life Sci. 2022 Aug 10;79(9):478. |
| SK-MEL-28 | 15 µM | 72 h | Evaluate the cytotoxicity of Tpn on SK-MEL-28 cells, results showed IC50 was 15 µM | Cell Mol Life Sci. 2022 Aug 10;79(9):478. |
| A375 | 3 µM | 72 h | Evaluate the cytotoxicity of Tpn on A375 cells, results showed A375 cells were highly sensitive to Tpn | Cell Mol Life Sci. 2022 Aug 10;79(9):478. |
| BV2 cells | 10 μM | 24 h | Tryptanthrin inhibited microglia-derived inflammation by promoting polarization to the M2 phenotype. | Neural Regen Res. 2025 Nov 1;20(11):3287-3301. |
| BV2 cells | 2.5-50 μM | 3, 6, 12, 24 h | Evaluated the effects of tryptanthrin on BV2 cell viability and found that tryptanthrin was not cytotoxic at concentrations lower than 10.0 μM within 24 h. | Neural Regen Res. 2025 Nov 1;20(11):3287-3301. |
| Human foreskin fibroblasts | 18 μM | 72 h | To assess the toxicity of Tryptanthrin on normal cells, results showed only 22% cell death at 18 μM. | Cell Prolif. 2020 Jan;53(1):e12710. |
| A431 cells | 9 μM | 72 h | To assess the cytotoxicity of Tryptanthrin on A431 cells, results showed significant cytotoxicity at 9 μM. | Cell Prolif. 2020 Jan;53(1):e12710. |
| mouse bone marrow-derived neutrophils | 0.1 µM–10 µM | 4 h | TRYP dose-dependently reduced OSM release in GM-CSF-stimulated mouse bone marrow-derived neutrophils. | Nutrients. 2024 Nov 28;16(23):4109. |
| neutrophils-like differentiated (d)HL-60 cells | 0.1 µM–10 µM | 1 h | TRYP dose-dependently reduced OSM release and mRNA expression levels in GM-CSF-stimulated neutrophils-like dHL-60 cells. | Nutrients. 2024 Nov 28;16(23):4109. |
| Administration | Dosage | Frequency | Description | References | ||
| BALB/c mice | WEHI-3B JCS cell-induced leukemia model | Intraperitoneal injection | 0.04, 0.08, 0.16 mg/kg | 5 consecutive days | Tryptanthrin significantly suppressed the growth of WEHI-3B JCS cells in BALB/c mice, with significant effects at doses of 0.08 and 0.16 mg/kg. | Cell Mol Immunol. 2009 Oct;6(5):335-42. |
| BALB/c nude mice | Liver cancer xenograft model | Intraperitoneal injection | 100 mg/kg | Daily until the end of the experiment | Inhibits tumor growth and induces tumor cell senescence | Redox Biol. 2024 Oct;76:103323. |
| NOD-SCID mice | Melanoma xenograft model | Intradermal injection | 12 mg/kg | Daily for one month | Evaluate the inhibitory effect of Tpn on melanoma growth in vivo, results showed Tpn significantly reduced tumor volume and metastasis | Cell Mol Life Sci. 2022 Aug 10;79(9):478. |
| C57BL/6 male mice | Spinal cord injury model | Intragastric administration | 30 mg/kg | Once daily for 14 days | Tryptanthrin promoted microglia polarization toward M2 phenotype by targeting the cGAS/STING/NF-κB axis, inhibited neuronal loss, and promoted tissue repair and functional recovery. | Neural Regen Res. 2025 Nov 1;20(11):3287-3301. |
| Swiss albino mice | DMBA/PMA-induced skin carcinogenesis model | Topical application | 0.5 mg or 1 mg | 1 hour before each PMA application, for 16 weeks | To evaluate the inhibitory effect of Tryptanthrin on skin cancer, results showed 60.1% reduction in tumor size and 59% reduction in tumor multiplicity at 1 mg dose. | Cell Prolif. 2020 Jan;53(1):e12710. |
| Galleria mellonella | Infection model | Injection | 50 mg/kg | Single injection, observed for 96 hours | Evaluated the effect of tryptanthrin on the virulence of A. baumannii, survival rate increased from 40% to 80% | iScience. 2024 May 8;27(6):109942. |
| Male SD mice | DSS-induced colitis model | Intragastrical administration | 39.2 mg/kg, 78.4 mg/kg, 156.8 mg/kg | Twice a day for 8 days | Tryptanthrin improves the health condition of mice with DSS-induced colitis by regulating the TNF-α/NF-κB and IL-6/STAT3 signaling pathways. | Molecules. 2018 May 2;23(5):1062 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.03mL 0.81mL 0.40mL |
20.14mL 4.03mL 2.01mL |
40.28mL 8.06mL 4.03mL |
|
| CAS号 | 13220-57-0 |
| 分子式 | C15H8N2O2 |
| 分子量 | 248.24 |
| SMILES Code | O=C1C2=CC=CC=C2N2C1=NC1=CC=CC=C1C2=O |
| MDL No. | MFCD00012073 |
| 别名 | NSC 349447 |
| 运输 | 蓝冰 |
| InChI Key | VQQVWGVXDIPORV-UHFFFAOYSA-N |
| Pubchem ID | 73549 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, room temperature |
| 溶解方案 |
DMSO: 6 mg/mL(24.17 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1